Choosing appropriate patient-reported outcome measures for prostate disease

BJUI Compass. 2022 Jan 12;3(4):263-266. doi: 10.1002/bco2.136. eCollection 2022 Jul.

Alexander Ng^{1

2}, Pramit Khetrapal^{3

4}, Chris Brew-Graves⁵, Nicola Muirhead⁵, Aqua Asif^{6

2}, Vinson Wai-Shun Chan^{7

2}, Arjun Nathan^{2

3}, Veeru Kasivisvanathan^{2

3}

¹ UCL Medical School University College London London UK.
² British Urology Researchers in Surgical Training (BURST) London UK.
³ Division of Surgery and Interventional Science UCL London UK.
⁴ Department of Urology Whipps Cross Hospital, Barts Health NHS Trust London UK.
⁵ National Cancer Imaging Translational Accelerator (NCITA), Division of Medicine UCL London UK.
⁶ Leicester Medical School University of Leicester Leicester UK.
⁷ School of Medicine, Faculty of Medicine and Health University of Leeds Leeds UK.

No abstract available

Keywords: approval; education; patient‐reported outcome measure; prostate; prostate disease.